Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition

Neuropsychopharmacology

Volumn 19, Issue 1, 1998, Pages 86-94

  Wiley, Jenny L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotics; Nitric oxide synthase inhibitors; NMDA antagonists; Phencyclidine; Schizophrenia

Indexed keywords

7 NITROINDAZOLE; ARCAINE; ELIPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEGATIVE FEEDBACK; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BIGUANIDES; BIOGENIC POLYAMINES; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; INDAZOLES; INHIBITION (PSYCHOLOGY); MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; PHENCYCLIDINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION;

EID: 0031800007     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00008-6     Document Type: Article

References (47)

1. Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiat. 50:1993;169-177.
2. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE, Jones EG Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiat. 50:1993;178-187.
3. Bakshi VP, Geyer MA Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
4. Bakshi VP, Swerdlow NR, Geyer MA Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1994;787-794.
5. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
6. Carter C, Rivy JP, Scatton B Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol. 164:1989;611-612.
7. Chapman PF, Atkins CM, Allen MT, Haley JE, Steinmetz JE Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport. 3:1992;567-570.
8. Connop BP, Rolfe NG, Boegman RJ, Jhamandas K, Beninger RJ Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439-1445.
9. Das I, Khan NS, Puri BK, Sooranna SR, de Belleroche J, Hirsch SR Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Comm. 22:1995;375-380.
10. Deutsch SI, Rosse RB, Paul SM, Tomasino V, Koetzner L, Morn CB, Mastropaolo J 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology. 15:1996;37-43.
11. Ellenbroek BA, Cools AR Animal models with construct validity for schizophrenia. Behav Pharmacol. 1:1990;469-490.
12. Garthwaite J Glutamate, nitric oxide and cell-cell signalling in the nervous system. Tr Neurosci. 14:1991;60-67.
13. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull. 25:1990;485-498.
14. Hoffman DC, Donovan H, Cassella JV The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology. 111:1993;339-344.
15. Hu J, Lee JH, El-Fakahany EE Inhibition of neuronal nitric oxide synthase by antipsychotic drugs. Psychopharmacology. 114:1994;161-166.
16. Jewett DC, Butelman ER, Woods JH Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Res. 715:1996;25-31.
17. Johansson C, Jackson DM, Svensson L The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology. 116:1994;437-442.
18. Johansson C, Jackson DM, Svensson L Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131:1997;167-173.
19. Kabuto H, Yokoi I, Habu H, Asahara H, Mori A Inhibitory effect of arcaine on nitric oxide synthase in the rat brain. NeuroReport. 6:1995;554-556.
20. Karson CN, Garcia-Rill E, Biedermann J, Mrak RE, Husain MM, Skinner RD The brain stem reticular formation in schizophrenia. Psychiat Res Neuroimag. 40:1991;31-48.
21. Keith VA, Mansbach RS, Geyer MA Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of acoustic startle. Biol Psychiatr. 30:1991;557-566.
22. Khanna JM, Morato GS, Shah G, Chau A, Kalant H Inhibition of nitric oxide synthesis impairs rapid tolerance to ethanol. Brain Res Bull. 32:1993;43-47.
23. G-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol. 221:1992;399-400.
24. Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS, McDonald IA Nitric oxide in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci. 48:1991;69-75.
25. 3H]dopamine release from striatal slices. J Neurosci Res. 35:1993;192-198.
26. Majeed NH, Przewlocka B, Machelska H, Przewlocki R Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
27. Mansbach RS, Geyer MA, Braff DL Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
28. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;653-662.
29. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973-977.
30. Nagafusi T, Sugiyama M, Muto A, Makino T, Miyauchi T, Nabata H The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. NeuroReport. 6:1995;1541-1545.
31. 3H]dopamine uptake. Brain Res. 641:1994;83-91.
32. Pudiak CM, Bozarth MA L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effects of cocaine. Life Sci. 53:1993;1517-1524.
33. Reynolds IJ Arcaine is a competitive antagonist of the polyamine site on the NMDA receptor. Eur J Pharmacol. 177:1990;215-216.
34. Rundfeldt C, Koch R, Richter A, Mevissen M, Gerecke U, Loscher W Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol. 274:1995;73-81.
35. Schulz JB, Matthews RT, Muqit MMK, Browne SE, Beal MF Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem. 64:1995;936-939.
36. Squires RF, Saederup E A review of evidence for GABergic predomininace/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses. More support for a continuum hypothesis of "functional" psychosis Neurochem Res. 16:1991;1099-1111.
37. Stewart J, Deschamps SE, Amir S Inhibition of nitric oxide synthase does not block development of sensitization to the behavioral activating effects of amphetamine. Brain Res. 641:1994;141-144.
38. Swerdlow NR, Geyer MA Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 44:1993;741-744.
39. Swerdlow NR, Bakshi V, Geyer MA Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 279:1996;1290-1299.
40. Swerdlow NR, Keith VA, Braff DL, Geyer MA Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther. 256:1991;530-536.
41. Swerdlow NR, Zisook D, Taaid N Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats. Similarities to clozapine Psychopharmacology. 114:1994;675-678.
42. Volke V, Soosaar A, Koks S, Bourin M, Mannisto PT, Vasar E 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology. 131:1997;399-405.
43. Wiley JL Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response. Pharmacol Biochem Behav. 49:1994;1025-1028.
44. Wiley JL NOS inhibitors attenuate PCP-induced disruption of prepulse inhibition. Pharmacol Biochem Behav. 57:1997;623.
45. Wiley JL, Cristello AF, Balster RL Effects of site-selective NMDA antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol. 294:1995;101-107.
46. Wiley JL, Golden KM, Bowen SE Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats. Eur J Pharmacol. 328:1997;125-130.
47. Yamada K, Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, Nabeshima T Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol. 115:1995;852-858.